CDK1 and cervical carcinoma: A previous study suggested that lower expression of hsa-miR-6705-5p was markedly correlated with the poor prognosis of cervical cancer, which could inhibit the progression of cervical cancer via targeting CDK1 (Mei et al., 2020).